Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation
- 1 July 2017
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 155, 266-275
Abstract
No abstract availableKeywords
Funding Information
- PON a3_0035
This publication has 38 references indexed in Scilit:
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved DrugsJournal of Pharmaceutical Sciences, 2016
- Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic responseEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Gemcitabine-Loaded Biocompatible Nanocapsules for The Effective Treatment of Human CancerNanomedicine, 2013
- State of the art in PEGylation: The great versatility achieved after forty years of researchJournal of Controlled Release, 2012
- Improved In Vitro Anti-Tumoral Activity, Intracellular Uptake and Apoptotic Induction of Gemcitabine-Loaded Pegylated Unilamellar LiposomesJournal of Nanoscience and Nanotechnology, 2008
- Sheddable Coatings for Long-Circulating NanoparticlesPharmaceutical Research, 2007
- New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?Nanomedicine, 2006
- Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProgress in Lipid Research, 2003
- Enhanced Therapeutic Effect of Cytidine-5′ -Diphosphate Choline when Associated with GM1 Containing Small Liposomes as Demonstrated in a Rat Ischemia ModelPharmaceutical Research, 1995
- Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activityInternational Journal of Pharmaceutics, 1995